Muddasser Saiyed-Javed, MBBS

Muddasser Saiyed-Javed practices at University Hospital in Ann Arbor, Michigan.

Muddasser Saiyed-Javed's NPI, 1417105420, was assigned on September 3, 2008. Muddasser Saiyed-Javed holds Michigan license 4301091689.

Muddasser Saiyed-Javed's primary practice is University Hospital, at 1500 E Medical Center Dr, Ann Arbor, MI 48109. The practice phone is (734) 936-4000.

Muddasser Saiyed-Javed's primary practice is University Hospital in Ann Arbor, Michigan. Muddasser Saiyed-Javed is also affiliated with University Hospital. The medical group on file is University of Michigan Health. Dmand AI also links Muddasser Saiyed-Javed to 4 more medical groups and 1 dialysis center, each named with a free account. Muddasser Saiyed-Javed's employer is on file too: a school & student health.

Dmand AI tracks the electronic health record (EHR) system at each site where Muddasser Saiyed-Javed practices, 3 sites in all. Vendor and product names are available with a free account.

Nephrology is Muddasser Saiyed-Javed's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dmand AI has Muddasser Saiyed-Javed's licenses on file in 2 states: Michigan and Ohio.

CMS data shows 817 Medicare services from Muddasser Saiyed-Javed across 6 procedure codes in 2024, for 261 Medicare patients. Medicare paid $74,193 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 261 Medicare patients who saw Muddasser Saiyed-Javed in 2024. The largest group is 75 to 84, with 93 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 32% are also on Medicaid. Their average risk score is 2.51, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Muddasser Saiyed-Javed's median patient age at 64, with 48% women.

In 2024, Muddasser Saiyed-Javed wrote 542 Medicare Part D claims for 190 patients. 83% of them were for generic drugs. CMS names the drug for 244 of them, across 14 drugs with 11 or more claims each, at $4,435 in total drug cost. In 2023, CMS named 289 claims across 15 drugs.

Muddasser Saiyed-Javed accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 5 general payments to Muddasser Saiyed-Javed from 5 drug and device companies from 2016 to 2023. Food and beverage make up the largest share, 100% of the total. Otsuka America Pharmaceutical, Inc. paid the most, $122.